NANOMEDICINE OPENS DOOR PRECISION MEDICINE BRAIN TUMORS

July 17, 2017 -

Source: RDmag.com

Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors.

The strategy involves using lipid polymer based nanoparticles to deliver molecules to the tumors, where the molecules shut down key cancer drivers called brain tumor initiating cells (BTICs).

“BTICs are malignant brain tumor populations that underlie the therapy resistance, recurrence and unstoppable invasion commonly encountered by glioblastoma patients after the standard treatment regimen of surgical resection, radiation and chemotherapy,” explained the study’s first author, Dr. Dou Yu, research assistant professor of neurological surgery at Northwestern University Feinberg School of Medicine.

Read more: https://www.rdmag.com/news/2017/07/nanomedicine-opens-door-precision-medicine-brain-tumors

Disclaimer: The opinions expressed within this article are the views of the writer and do not necessarily reflect the views and opinions of ASME.


 
ASME Insider Home Latest News Key Issues ASME Members Outreach Washington Insider Contact Us